Earnings ·
OrthoPediatrics reports Q3 revenue of $72.7M, up 19%, and raises full-year guidance to $270M-$273M
KIDSOrthopediatrics Corp
OrthoPediatrics reported third-quarter 2026 revenue of $72.7 million, a 19% increase from the prior year period, driven by growth in Trauma & Deformity and Scoliosis product lines. The company achieved record adjusted EBITDA of $6.9 million and generated positive free cash flow of $1.6 million. Management increased full-year 2026 revenue guidance to a range of $270.0 million to $273.0 million, reflecting expected growth of 14% to 16%. The company operates in the pediatric orthopedics medical device industry.